Skip to main content
. 2024 Apr 1;25:103. doi: 10.1186/s12875-024-02326-3

Table 2.

Summary of outcomes with significant results

Outcome criteria Intervention vs. control group Difference in change between Intervention and Control group P value
Carter B. (2009) [25] Proportion of patients with BP control at 6 months (%) 63.9 vs. 29.9 (OR 3.2, 95% CI 2.0-5.1) - p < 0.001
Proportion of patients with BP control without diabetes mellitus at 6 months (%) 68.8 vs. 32.4 (OR 3.9, 95% CI 3.1-5.0) - p < 0.001
Proportion of patients with BP control with diabetes mellitus at 6 months (%) 45.5 vs. 26.1 (OR 4.7, 95% CI 1.7–13.1) - p = 0.003
SBP at 6 months (mmHg) -20.7 vs. -6.8 - p < 0.05
Carter B. (2015) [26] SBP at 9 months (mmHg) 131.6 vs. 138.2 -6.1 (95% CI-9.75 to -2.39) * p = 0.002
DBP at 9 months (mmHg) 76.3 vs. 78.0 -2.9 (95% CI -4.85 to -0.93) * p = 0.005
SBP in minority ethnicity subjects at 9 months (mmHg) 133.0 vs. 140.3 -6.4 (95% CI -11.16 to -1.68) * p = 0.009
DBP in minority ethnicity subjects at 9 months (mmHg) 77.9 vs. 78.8 -2.9 (95% CI -5.88 to -0.08) * p = 0.044
Carter B. (2018) [27] Proportion of patients with Body Mass Index screening and follow-up at 12 months (%) 68.0 vs. 37.4 - p < 0.001
Proportion of patients with alcohol use screening at 12 months (%) 98.0 vs. 88.2 - p < 0.001
Chen Z. (2013) [28] 24-hour SBP at 6 months (mmHg) 120.4 vs. 131.8 - p < 0.001
Proportion of patients with BP control at 6 months (%) 75.6 vs. 50.0 - p < 0.001
Finley P. (2002) [39] 6-months Medication Possession ratio (MPR) 0.811 vs. 0.659 - p < 0.005
Patient satisfaction survey results at 6 months Patients in intervention group were more likely to have received an antidepressant previously: 25.0% vs. 19.0% - p = 0.044
Finley P. (2003) [40] Patient satisfaction survey results at 6 months Patients in the intervention group expressed greater satisfaction than did control group with the personal nature of care, availability of providers, ability of providers to listen, explanation of why antidepressants were prescribed, explanation of how to take the antidepressants and patient’s overall satisfaction with the health maintenance organization - p < 0.05
Hogg W. (2009) [30] Number of patients with influenza vaccination - 0.087 (95% CI 0.012–0.162) ** p = 0.023
Number of patients with screening for colorectal cancer - 0.167 (95% CI 0.046–0.288) ** p = 0.0070
Number of patients with hearing examination - 0.273 (95% CI 0.106–0.44) ** p = 0.0016
Number of patients with eye examination - 0.220 (95% CI 0.076–0.364) ** p = 0.0029
Jameson J. (2010) [31] HbA1c for male patients at 12 months (%) -1.90 vs. -0.15 - p = 0.03
Proportion of patients who achieved at least a 1.0% decrease in HbA1c at 12 months (%) 67.3 vs. 41.2 - p = 0.02
Proportion of patients who achieved at least a 1.0% decrease in HbA1c for patients of nonwhite race/ethnicity at 12 months (%) 56.3 vs. 22.7 - p = 0.03
Proportion of patients who achieved at least a 1.0% decrease in HbA1c for male patients at 12 months (%) 72.0 vs. 28.0 - p = 0.002
Pape G. (2011) [33] LDL-C at 24 months (mg/dl) 83.0 vs. 95.0 - p < 0.001
Proportion of patients with LDL-C at target goal at 24 months (%) 78.0 vs. 50.0 - p = 0.003
Proportion of patients with LDL-C at target if they were not at goal baseline at 24 months (%) 74.0 vs. 48.0 - p = 0.001
Proportion of patients with LDL-C test within the past 12 months at 24 months (%) 95.0 vs. 82.0 - p = 0.04
Simpson S. (2011) [34] Proportion of patients with diminution of 10.0% of SBP at 12 months (%) 37.0 vs. 23.0 (OR 1.91, 95% CI 1.11–3.28) - p = 0.02
Proportion of patients with elevated blood pressure at baseline with diminution of 10.0% of SBP at 12 months (%) 50.0 vs. 28.0 (OR 2.55, 95% CI 1.30–5.01) - p = 0.007
SBP at 12 months (mmHg) -7.4 vs. -2.5 -4.9 (95% CI -8.7 to -1.0) * p = 0.002
DBP at 12 months (mmHg) -2.3 vs. 0.6 -2.9 (95% CI -5.6 to -0.2) * p < 0.05
SBP for patients with elevated blood pressure at 12 months (mmHg) -13.9 vs. -6.7 - p = 0.002
Predicted 10-year risk of cardiovascular events at 12 months (%) -2.7 vs. -1.2 -1.5 (95% CI -0.2 to 3.3) * p = 0.005
Smith S. (2016) [35] SBP at 9 months (mmHg) 132 ± 16 vs. 141 ± 20 -6.62 (95% CI -12.8 to -0.44) * p = 0.036
Proportion of patients with an improvement from low to high medication adherence minority ethnicity subjects (antihypertensive use) at 9 months (%) 8.1 vs. 0.0 - p = 0.016
Tahaineh L. (2011) [36] Proportion of patients reached their LDL-C goal at 6 months (%) 94.5 vs. 71.2 - p < 0.001
Proportion of patients reached their total cholesterol goal at 6 months (%) 87.7 vs. 73.1 - p = 0.038
Proportion of patients reached their HDL-C goal at 6 months (%) 28.8 vs. 50.0 - p = 0.016
Tobari H. (2010) [37] DBP at home at 6 months (mmHg) -3.3 (-4.8 to -1.8) vs. -1.4 (-2.9 to 0.1) -2.8 (95% CI -5.5 to -0.1) * p = 0.04
Body Mass Index at 6 months (kg/m²) -0.4 (-0.7 to -0.2) vs. 0.0 (-0.2 to 0.2) -0.4 (95% CI -0.7 to -0.1) * p = 0.008
Sodium reduction score at 6 months 1.3 (0.9 to 1.7) vs. 0.0 (-0.4 to 0.4) 1.2 (95% CI 0.5-2.0) ** p = 0.002
Number of smokers at 6 months 9.0 [14.0] vs. 19.0 [30.0] 0.4 (95% CI 0.2–0.9) ** p = 0.04
Weber C. (2010) [38] Change in 24-hour SBP at 9 months (mmHg) 136.0 to 130.5 vs. 135.5 to 121.4 - p < 0.001
Change in 24-hour DBP at 9 months (mmHg) 76.6 to 73.7 vs. 76.0 to 69.2 - p < 0.001

Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; HbA1c, glycosylated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure

Legend: Bold text:primary outcomes of study;*Negative values indicate Intervention Group has larger change; **Positive values indicate Intervention Group has larger change